Acasti Pharma Inc. (ACST)

Acasti Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	27	32	21	54	108	34
Market Cap Growth	56.91%	56.91%	-62.03%	-49.83%	218.66%	-57.59%
Enterprise Value	10	9	-7	11	47	20
PE Ratio	-	-2.50	-0.48	-5.50	-5.47	-1.32
PS Ratio	-	-	-	-	549.48	-
PB Ratio	0.59	0.52	0.30	0.50	1.94	2.60
P/FCF Ratio	-2.63	-2.63	-1.29	-3.14	-7.49	-1.45
P/OCF Ratio	-2.61	-2.61	-1.29	-3.14	-7.52	-1.47
EV/Sales Ratio	-	-	-	-	240.06	-
EV/EBITDA Ratio	-0.59	-0.59	0.13	-1.02	-2.51	-0.89
EV/EBIT Ratio	-0.59	-0.59	0.13	-1.02	-2.39	-0.81
EV/FCF Ratio	-0.75	-0.75	0.43	-0.62	-3.27	-0.85
Debt / Equity Ratio	-	-	0.01	0.00	0.00	0.01
Debt / EBITDA Ratio	-	-	-0.01	-0.03	0.00	-0.01
Debt / FCF Ratio	-	-	-0.03	-0.02	-0.01	-0.01
Quick Ratio	14.09	14.09	8.41	13.56	38.80	2.00
Current Ratio	14.26	14.26	8.59	13.89	39.50	2.50
Asset Turnover	0	0	0	0	0.01	0
Interest Coverage	-	-	-	-	-	-22.73
Return on Equity (ROE)	-20.00%	-20.00%	-46.00%	-10.10%	-77.70%	-1049.40%
Return on Assets (ROA)	-17.10%	-17.10%	-38.40%	-9.30%	-62.10%	-92.10%
Return on Capital (ROIC)	-20.82%	-20.82%	-76.21%	-14.36%	-29.45%	-185.97%
Earnings Yield	-47.98%	-39.92%	-206.79%	-18.17%	-18.27%	-75.49%
FCF Yield	-33.43%	-38.03%	-77.64%	-31.90%	-13.36%	-68.85%
Buyback Yield / Dilution	-28.16%	-28.16%	-21.09%	-148.46%	-40.25%	-55.80%
Total Shareholder Return	-28.16%	-28.16%	-21.09%	-148.46%	-40.25%	-55.80%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).